Page last updated: 2024-08-26

diosgenin and Pancreatic Neoplasms

diosgenin has been researched along with Pancreatic Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Xiao, MF1
Chen, Y; Gao, J; Guo, W; Li, K; Liu, X; Nie, C; Tang, M; Wei, H; Yuan, Z; Zhao, X; Zhong, K1
Gao, S; Hao, J; Ren, H; Zhao, X1
Han, X; Liu, K; Peng, J; Qi, Y; Si, L; Xu, L; Xu, Y; Yin, L; Zhao, Y1
Anchoori, RK; Carducci, MA; Davidson, N; Hidalgo, M; Jimeno, A; Kachhap, S; Khan, SR; Shabbeer, S; Sobolewski, M1

Other Studies

5 other study(ies) available for diosgenin and Pancreatic Neoplasms

ArticleYear
[Effect of polyphyllin D on proliferation and apoptosis of human pancreatic cancer cells].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2020, Volume: 45, Issue:6

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Diosgenin; Humans; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Saponins

2020
Diosgenin exhibits tumor suppressive function via down-regulation of EZH2 in pancreatic cancer cells.
    Cell cycle (Georgetown, Tex.), 2019, Volume: 18, Issue:15

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Diosgenin; Enhancer of Zeste Homolog 2 Protein; G2 Phase Cell Cycle Checkpoints; Gene Silencing; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; PTEN Phosphohydrolase; RNA, Small Interfering; Transplantation, Heterologous; Up-Regulation; Vimentin

2019
[Effects of dioscin on apoptosis in pancreatic cancer MiaPaCa-2 cells and its mechanism].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2014, Volume: 36, Issue:1

    Topics: Apoptosis; Diosgenin; Humans; Pancreatic Neoplasms; Peroxiredoxins; Reactive Oxygen Species

2014
Potent effects of dioscin against pancreatic cancer via miR-149-3P-mediated inhibition of the Akt1 signalling pathway.
    British journal of pharmacology, 2017, Volume: 174, Issue:7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Diosgenin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Neoplasms, Experimental; Pancreatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; Structure-Activity Relationship; Tumor Cells, Cultured

2017
Fenugreek: a naturally occurring edible spice as an anticancer agent.
    Cancer biology & therapy, 2009, Volume: 8, Issue:3

    Topics: Anticarcinogenic Agents; Breast Neoplasms; Cell Death; Cell Line, Tumor; Diosgenin; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; Male; Neoplasm Proteins; Neoplasms; Pancreatic Neoplasms; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Signal Transduction; Spices; Sulfoxides; Thiocyanates; Trigonella

2009